Dishman Carbogen Amcis Limited
NSE: DCAL.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Himani S. Dhotre
- Employees
- 1,132
- Headquarters
- Ahmedabad, India
- IPO year
- 2004
- Market cap
- ₹29.4B
- Website
- https://imdcal.com
Loading DCAL…
Loading profile data…Frequently asked questions about DCAL
What does Dishman Carbogen Amcis Limited (DCAL.NS) do?
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium comp...
Where does DCAL.NS trade?
Dishman Carbogen Amcis Limited (DCAL.NS) trades on the National Stock Exchange of India.
What sector is DCAL.NS in?
Dishman Carbogen Amcis Limited (DCAL.NS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Dishman Carbogen Amcis Limited?
Himani S. Dhotre is the chief executive officer of Dishman Carbogen Amcis Limited (DCAL.NS).
Where is Dishman Carbogen Amcis Limited headquartered?
Dishman Carbogen Amcis Limited is headquartered in India.
Does DCAL.NS pay a dividend?
Dishman Carbogen Amcis Limited (DCAL.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DCAL.NS go public?
Dishman Carbogen Amcis Limited (DCAL.NS) completed its initial public offering in 2004.